Back
Customers Bancorp Vs. Aligos Therapeutics Industry Stock Comparison
Buy
70
CUBI
Customers Bancorp
Last Price:
54.24
Seasonality Move:
9.27%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
32.60
Seasonality Move:
10.65%
Buy
70
Customers Bancorp (CUBI)
is a Buy
Is Customers Bancorp a Buy, Sell or Hold?
- The current Customers Bancorp [CUBI] share price is $53.31. The Score for CUBI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- CUBI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUBI Stock Price Chart
What is Customers Bancorp's stock price today?
-
The Customers Bancorp share price today is $53.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CUBI is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CUBI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 48.51 | Sell |
| Chaikin Money Flow: | -213101 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.64 - 57) | Sell |
| Bollinger Bands (100): | (45.33 - 56.39) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.32 | Buy |
| Relative Strength Index (14 RSI): | 81.62 | Buy |
| Chaikin Money Flow: | 315379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.3 - 26.46) | Buy |
| Bollinger Bands (100): | (7.85 - 19.03) | Buy |
CUBI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.99 | Sell |
| 20-day SMA: | 55.36 | Sell |
| 50-day SMA: | 50.37 | Buy |
| 200-day SMA: | 50.18 | Buy |
| 8-day EMA: | 54.71 | Sell |
| 20-day EMA: | 54.3 | Sell |
| 50-day EMA: | 52.11 | Buy |
| 200-day EMA: | 49.39 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 22.81 | Buy |
| 50-day SMA: | 14.24 | Buy |
| 200-day SMA: | 15.81 | Buy |
| 8-day EMA: | 27.13 | Buy |
| 20-day EMA: | 22.88 | Buy |
| 50-day EMA: | 17.49 | Buy |
| 200-day EMA: | 15.94 | Buy |
Customers Bancorp Earnings Growth & CUBI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.72 per share, and an increase next year of $0.56 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Customers Bancorp Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||